Doximity, Inc. (DOCS)

USD 56.88

(-1.51%)

EBITDA Summary of Doximity, Inc.

  • Doximity, Inc.'s latest annual EBITDA in 2024 was 195.46 Million USD , up 45.54% from previous year.
  • Doximity, Inc.'s latest quarterly EBITDA in 2024 FY was N/A , up 34.48% from previous quarter.
  • Doximity, Inc. reported an annual EBITDA of 125.1 Million USD in 2023, up 14.18% from previous year.
  • Doximity, Inc. reported an annual EBITDA of 113.53 Million USD in 2022, up 108.01% from previous year.
  • Doximity, Inc. reported a quarterly EBITDA of 44.4 Million USD for 2024 Q4, down -27.28% from previous quarter.
  • Doximity, Inc. reported a quarterly EBITDA of 52.26 Million USD for 2024 Q2, up 49.35% from previous quarter.

Annual EBITDA Chart of Doximity, Inc. (2024 - 2019)

Created with Highcharts 11.1.0YearsEBITDA20192019.520202020.520212021.520222022.520232023.520240 USD50000000 USD100000000 USD150000000 USD200000000 USD250000000 USD

Historical Annual EBITDA of Doximity, Inc. (2024 - 2019)

Year EBITDA EBITDA Growth
2024 195.46 Million USD 45.54%
2023 125.1 Million USD 14.18%
2022 113.53 Million USD 108.01%
2021 63.9 Million USD 147.17%
2020 26.41 Million USD 208.66%
2019 7.47 Million USD 0.0%

Peer EBITDA Comparison of Doximity, Inc.

Name EBITDA EBITDA Difference
American Well Corporation -225.99 Million USD 186.493%
Evolent Health, Inc. -24.78 Million USD 888.65%
MultiPlan Corporation 651.93 Million USD 70.017%
Phreesia, Inc. -102.94 Million USD 289.875%
Teladoc Health, Inc. 153.99 Million USD -26.929%
Veeva Systems Inc. 429.33 Million USD 54.472%